DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines

Protein Cell. 2023 Jun 28;14(7):532-537. doi: 10.1093/procel/pwac028.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gemcitabine*
  • Humans
  • Neoplasms*

Substances

  • Gemcitabine